All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @thegaygreenwitch on TikTok · 60s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @thegaygreenwitch's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Alright, here we are on week 13. Hard to believe it's already been like what is that basically three months now of doing these injections
  2. 0:08But I am holding study today at
  3. 0:11402 pounds
  4. 0:12Which kind of actually took me by surprise because I did skip a night at the gym this week and I've been a little bit
  5. 0:20Lacks about what I've been eating so I'm actually kind of impressed that I'm still at 402
  6. 0:26And I'm like by matters of ounces less than the 402 I was last week so small small victory
  7. 0:34But very glad to see that
  8. 0:37Definitely starting to see some shape and some muscle really coming in so really happy about that and
  9. 0:44That is week 13
  10. 0:46And I forgot to mention this week we are upping the dose to the maximum dose of 50 units or I can't remember how many
  11. 0:54Milgrams that is
  12. 0:55But it's 50 units so we are at max dose as of this week

Compounded semaglutide 'max dose': what 50 units actually means

Langston August

TikTok creator

14.2K viewsWatch on TikTok

Quick answer

The creator is at week 13 of compounded semaglutide therapy, reporting 402 pounds with minimal week-over-week change despite reduced gym attendance and looser dietary adherence, which is consistent with GLP-1 receptor agonist appetite suppression operating independently of exercise behavior. They are escalating to what their provider calls the maximum dose, described as 50 units of solution, but the milligram equivalent is unknown because compounded semaglutide concentration varies by pharmacy. Without knowing the mg/mL concentration of the compounded formulation, the clinical significance of a "50 unit" dose cannot be evaluated.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Compounded semaglutide 'max dose': what 50 units actually means, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Compounded semaglutide 'max dose': what 50 units actually means" from Langston August. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is at week 13 of compounded semaglutide therapy, reporting 402 pounds with minimal week-over-week change despite reduced gym attendance and looser dietary adherence, which is consistent with GLP-1 receptor agonist appetite suppression operating independently of exercise behavior.

The reason this review is not generic is the source wording and the canonical claim label "glp1 week 13 402lbs today i start on the max dosage for the compo." In this clip, the useful excerpt is: "Alright, here we are on week 13." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

FDA-approved Wegovy peaks at 2.
People who land here are usually comparing the Compounded Semaglutide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator is at week 13 of compounded semaglutide therapy, reporting 402 pounds with minimal week-over-week change despite reduced gym attendance and looser dietary adherence, which is consistent with GLP-1 receptor agonist appetite suppression operating independently of exercise behavior.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is at week 13 of compounded semaglutide therapy, reporting 402 pounds with minimal week-over-week change despite reduced gym attendance and looser dietary adherence, which is consistent with GLP-1 receptor agonist appetite suppression operating independently of exercise behavior. They are escalating to what their provider calls the maximum dose, described as 50 units of solution, but the milligram equivalent is unknown because compounded semaglutide concentration varies by pharmacy. Without knowing the mg/mL concentration of the compounded formulation, the clinical significance of a "50 unit" dose cannot be evaluated.
  • 50 units on a syringe is a volume measurement, not a milligram dose. At 5 mg/mL concentration it equals 2.5 mg; at 2 mg/mL it equals 1.0 mg. Know your vial concentration.
  • FDA-approved Wegovy peaks at 2.4 mg/week per Wilding et al. (2021, NEJM). Compounded semaglutide is not the same product and cannot be assumed equivalent in dose, stability, or bioavailability.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • 50 units on a syringe is a volume measurement, not a milligram dose. At 5 mg/mL concentration it equals 2.5 mg; at 2 mg/mL it equals 1.0 mg. Know your vial concentration.
  • FDA-approved Wegovy peaks at 2.4 mg/week per Wilding et al. (2021, NEJM). Compounded semaglutide is not the same product and cannot be assumed equivalent in dose, stability, or bioavailability.
  • Weight stability at week 13 is consistent with clinical data. Tschop and Friedman (2023, Nature Metabolism) describe a predictable plateau in GLP-1 driven weight loss around weeks 12 to 16.
  • GLP-1 receptor agonists suppress appetite independently of exercise behavior. Missing a gym session does not neutralize the drug's mechanism, which is why the creator held steady despite a looser week.
  • The FDA removed semaglutide from its drug shortage list in 2024, which has direct legal implications for compounding pharmacies producing it. Patients using compounded versions should confirm their pharmacy's compliance status.
  • Dose escalation of any semaglutide formulation should be directed by a licensed prescriber. The creator's framing, that their provider set this schedule, is the correct approach and worth modeling for viewers.
  • Calling any compounded dose a 'max dose' without milligram confirmation is not a safe communication shortcut. Viewers who replicate unit-based dosing language without knowing their vial concentration risk significant dosing errors.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @thegaygreenwitch actually say?

At week 13 of their semaglutide journey, the creator reported holding steady at 402 pounds despite skipping a gym session and being "a little bit lax" about eating. They also announced moving to "the maximum dose of 50 units" of compounded semaglutide, adding that they couldn't recall the milligram equivalent. That last detail matters more than they realized.

To be fair, the creator is not making dramatic health claims here. They are documenting a real, ongoing weight loss experience with refreshing honesty about imperfect weeks. They notice body composition changes, they acknowledge the scale barely moved, and they frame it as a "small small victory." That is a reasonable read of the data in front of them. The problem is the phrase "max dose" and the unit confusion that comes with it.

Does the science back this up?

The weight stability despite a skipped workout and relaxed eating is actually consistent with how semaglutide works. The drug does not require gym attendance to suppress appetite. That part checks out.

On dosing, things get complicated fast. FDA-approved Wegovy tops out at 2.4 mg per week. Ozempic's labeled ceiling is 2 mg. Compounded semaglutide is typically prepared as a solution, often at concentrations like 5 mg/mL or 10 mg/mL. "50 units" on an insulin syringe equals 0.5 mL, which means the actual milligram dose depends entirely on the concentration of the vial, a number the creator admits they do not know. Wilding et al. (2021, NEJM) established the 2.4 mg/week dose as the efficacy benchmark in the STEP 1 trial. Whether 50 units of a compounded solution equals, exceeds, or falls short of that dose is impossible to determine from this video alone.

What did they get wrong (or right)?

Right: Attributing weight stability to the drug's appetite-suppressing mechanism is defensible. The GLP-1 receptor agonist literature consistently shows that caloric reduction is largely passive, not dependent on exercise compliance. Davies et al. (2021, Lancet) confirmed meaningful weight reduction even in the absence of structured exercise protocols in the SCALE trial context.

Wrong, or at least incomplete: Calling 50 units the "max dose" without knowing the milligram equivalent is a meaningful gap. Compounded semaglutide is not the same product as branded Wegovy, and FormBlends is obligated to say that plainly. The FDA has repeatedly flagged compounded semaglutide for dosing inconsistencies and labeling issues. Calling any unit measurement a "max dose" without knowing the concentration is a bit like calling a full glass of liquid the maximum drink without knowing if it is water or espresso.

Also worth flagging: the creator says their provider set this dose, which is the right framework. This is not self-dosing. That matters.

What should you actually know?

"Units" is not a standardized semaglutide measurement. It is a syringe measurement. The actual dose in milligrams depends on the concentration of the compounded solution, which varies by pharmacy. If you are using compounded semaglutide and cannot answer the question "how many milligrams am I injecting," that is a conversation to have with your prescriber before the next dose, not after.

Compounded semaglutide is not FDA-approved and is not equivalent to Wegovy or Ozempic. The FDA placed semaglutide on and then removed it from the shortage list in 2024, which has legal implications for compounding pharmacies going forward. Rosenstock et al. and subsequent regulatory commentary have noted that compounded versions may differ in stability, excipients, and measurable bioavailability.

The creator's steady weight at week 13 is consistent with known GLP-1 plateau patterns. Tschop and Friedman (2023, Nature Metabolism) noted that weight loss with semaglutide often slows after 12 to 16 weeks as the body adjusts to the drug's satiety signaling. Holding steady is not failure. It may be biology.

The bottom line

This creator is doing something genuinely useful: documenting a real, imperfect weight loss experience with honesty. The week-13 weight stability is not alarming and is consistent with the clinical literature. But "50 units equals max dose" is not a complete or reliable statement without knowing the vial concentration, and viewers replicating this framing at home could be underdosing, overdosing, or simply confused. Know your milligrams, not just your units.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Langston August · TikTok creator

14.2K views on this video

Week 13, 402lbs! Today I start on the max dosage for the compounded semaglutide, 50 “units”, which is a pretty sizable slug of solution. #weightloss #exercise #nutrition #diet #workout #fitness

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about 50 units on a syringe?

50 units on a syringe is a volume measurement, not a milligram dose. At 5 mg/mL concentration it equals 2.5 mg; at 2 mg/mL it equals 1.0 mg. Know your vial concentration.

What does the video say about fda-approved wegovy peaks at 2.4 mg/week per wilding et al.?

FDA-approved Wegovy peaks at 2.4 mg/week per Wilding et al. (2021, NEJM). Compounded semaglutide is not the same product and cannot be assumed equivalent in dose, stability, or bioavailability.

What does the video say about weight stability at week 13?

Weight stability at week 13 is consistent with clinical data. Tschop and Friedman (2023, Nature Metabolism) describe a predictable plateau in GLP-1 driven weight loss around weeks 12 to 16.

What does the video say about glp-1 receptor agonists suppress appetite independently of exercise behavior. missing?

GLP-1 receptor agonists suppress appetite independently of exercise behavior. Missing a gym session does not neutralize the drug's mechanism, which is why the creator held steady despite a looser week.

What does the video say about the fda removed semaglutide from its drug shortage list in?

The FDA removed semaglutide from its drug shortage list in 2024, which has direct legal implications for compounding pharmacies producing it. Patients using compounded versions should confirm their pharmacy's compliance status.

Dose escalation of any semaglutide formulation should be directed by a licensed prescriber. The creator's framing, that their provider set this schedule, is the correct approach and worth modeling for viewers?

Dose escalation of any semaglutide formulation should be directed by a licensed prescriber. The creator's framing, that their provider set this schedule, is the correct approach and worth modeling for viewers.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Langston August, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.